SAVELLA
Generic: MILNACIPRAN HYDROCHLORIDE
AllerganManufacturer
ORALRoute
MILNACIPRAN HYDROCHLORIDEActive Substance
2009-01-14Original Approval
SAVELLA is FDA application NDA022256, sponsored by ABBVIE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
90 reports
2
VOMITING
88 reports
3
PAIN
83 reports
4
HYPOAESTHESIA
81 reports
5
MEMORY IMPAIRMENT
78 reports
6
ABDOMINAL PAIN UPPER
77 reports
7
PARAESTHESIA
76 reports
8
BLEPHAROSPASM
74 reports
9
DRUG INTOLERANCE
74 reports
10
EPILEPSY
74 reports